P

Pinteon Therapeutics

1 follower

Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.

Industries

Employees

1-10

Links


Org chart

Profile photo

Martin Jefson

Collapse
Michael Ahlijanian's profile picture
Michael Ahlijanian
Chief Scientific Officer
Larry Altstiel's profile picture
Larry Altstiel
Chief Medical Officer

Board & advisors


Offices